# PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms

> **NCT05825599** · NA · COMPLETED · sponsor: **C.O.C. Farmaceutici S.r.l.** · enrollment: 80 (actual)

## Conditions studied

- Dry Eye
- Dry Eye Disease
- Kerato Conjunctivitis Sicca

## Interventions

- **DEVICE:** Hydroxypropyl methylcellulose eye drops

## Key facts

- **NCT ID:** NCT05825599
- **Lead sponsor:** C.O.C. Farmaceutici S.r.l.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-06
- **Primary completion:** 2023-01-30
- **Final completion:** 2023-01-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05825599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05825599, "PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05825599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*